ENSG00000167258 |
|
colorectal adenocarcinoma |
frameshift_variant |
4.226% (56/1325) |
2 entries |
ENSG00000167258 |
|
HER2 Positive Breast Carcinoma |
missense_variant |
8.466% (16/189) |
2 entries |
ENSG00000167258 |
|
colon adenocarcinoma |
frameshift_variant |
3.79% (49/1293) |
3 entries |
ENSG00000167258 |
|
colorectal adenocarcinoma |
conservative_inframe_deletion |
4.226% (56/1325) |
2 entries |
ENSG00000167258 |
|
prostate adenocarcinoma |
missense_variant |
4.634% (100/2158) |
3 entries |
ENSG00000167258 |
|
prostate adenocarcinoma |
frameshift_variant |
4.634% (100/2158) |
3 entries |
ENSG00000167258 |
|
colorectal adenocarcinoma |
sequence_alteration |
4.226% (56/1325) |
2 entries |
ENSG00000167258 |
|
colon adenocarcinoma |
stop_gained |
3.79% (49/1293) |
2 entries |
ENSG00000167258 |
|
prostate adenocarcinoma |
amino_acid_insertion |
4.634% (100/2158) |
1 entry |
ENSG00000167258 |
|
prostate adenocarcinoma |
sequence_alteration |
4.634% (100/2158) |
2 entries |
ENSG00000167258 |
|
colorectal adenocarcinoma |
missense_variant |
4.226% (56/1325) |
3 entries |
ENSG00000167258 |
|
colon adenocarcinoma |
missense_variant |
3.79% (49/1293) |
6 entries |
ENSG00000167258 |
|
prostate adenocarcinoma |
stop_gained |
4.634% (100/2158) |
2 entries |
ENSG00000167258 |
|
ovarian serous adenocarcinoma |
stop_gained |
2.086% (19/911) |
2 entries |
ENSG00000167258 |
|
brain glioblastoma |
sequence_alteration |
0.9076% (11/1212) |
1 entry |
ENSG00000167258 |
|
prostate carcinoma |
stop_gained |
3.512% (17/484) |
1 entry |
ENSG00000167258 |
|
colorectal adenocarcinoma |
amino_acid_insertion |
4.226% (56/1325) |
1 entry |
ENSG00000167258 |
|
clear cell renal carcinoma |
missense_variant |
0.6766% (10/1478) |
2 entries |
ENSG00000167258 |
|
esophageal squamous cell carcinoma |
stop_gained |
1.895% (13/686) |
3 entries |
ENSG00000167258 |
|
prostate adenocarcinoma |
conservative_inframe_deletion |
4.634% (100/2158) |
1 entry |
ENSG00000167258 |
|
pancreatic ductal adenocarcinoma |
missense_variant |
1.863% (32/1718) |
1 entry |
ENSG00000167258 |
|
cecum adenocarcinoma |
missense_variant |
3.704% (10/270) |
1 entry |
ENSG00000167258 |
|
lung adenocarcinoma |
missense_variant |
1.362% (38/2789) |
6 entries |
ENSG00000167258 |
|
ovarian serous adenocarcinoma |
frameshift_variant |
2.086% (19/911) |
2 entries |
ENSG00000167258 |
|
embryonal rhabdomyosarcoma |
missense_variant |
2.326% (2/86) |
1 entry |
ENSG00000167258 |
|
skin melanoma |
stop_gained |
2.238% (26/1162) |
1 entry |
ENSG00000167258 |
|
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
2.615% (17/650) |
2 entries |
ENSG00000167258 |
|
breast carcinoma |
sequence_alteration |
1.584% (25/1578) |
1 entry |
ENSG00000167258 |
|
ovarian neoplasm |
missense_variant |
3.448% (2/58) |
1 entry |
ENSG00000167258 |
|
basal cell carcinoma |
missense_variant |
10.29% (7/68) |
2 entries |
ENSG00000167258 |
|
rectal adenocarcinoma |
missense_variant |
1.648% (9/546) |
2 entries |
ENSG00000167258 |
|
prostate carcinoma |
sequence_alteration |
3.512% (17/484) |
1 entry |
ENSG00000167258 |
|
ovarian serous adenocarcinoma |
conservative_inframe_deletion |
2.086% (19/911) |
2 entries |
ENSG00000167258 |
|
melanoma |
missense_variant |
5.517% (8/145) |
3 entries |
ENSG00000167258 |
|
lobular breast carcinoma |
missense_variant |
1.527% (4/262) |
1 entry |
ENSG00000167258 |
|
breast carcinoma |
missense_variant |
1.584% (25/1578) |
3 entries |
ENSG00000167258 |
|
urothelial carcinoma |
missense_variant |
8.14% (7/86) |
1 entry |
ENSG00000167258 |
|
gastric adenocarcinoma |
missense_variant |
2.019% (19/941) |
2 entries |
ENSG00000167258 |
|
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
missense_variant |
1.515% (4/264) |
2 entries |
ENSG00000167258 |
|
Endometrial Endometrioid Adenocarcinoma |
frameshift_variant |
2.615% (17/650) |
1 entry |
ENSG00000167258 |
|
prostate carcinoma |
missense_variant |
3.512% (17/484) |
1 entry |
ENSG00000167258 |
|
gastric intestinal type adenocarcinoma |
missense_variant |
3.529% (3/85) |
1 entry |
ENSG00000167258 |
|
breast ductal adenocarcinoma |
stop_gained |
2.959% (49/1656) |
1 entry |
ENSG00000167258 |
|
esophageal squamous cell carcinoma |
missense_variant |
1.895% (13/686) |
4 entries |
ENSG00000167258 |
|
Ovarian Carcinosarcoma |
frameshift_variant |
14.29% (2/14) |
1 entry |
ENSG00000167258 |
|
breast ductal adenocarcinoma |
sequence_alteration |
2.959% (49/1656) |
1 entry |
ENSG00000167258 |
|
squamous cell lung carcinoma |
missense_variant |
0.7984% (8/1002) |
3 entries |
ENSG00000167258 |
|
rectal adenocarcinoma |
frameshift_variant |
1.648% (9/546) |
1 entry |
ENSG00000167258 |
|
breast carcinoma |
stop_gained |
1.584% (25/1578) |
1 entry |
ENSG00000167258 |
|
basal cell carcinoma |
stop_gained |
10.29% (7/68) |
2 entries |
ENSG00000167258 |
|
breast ductal adenocarcinoma |
missense_variant |
2.959% (49/1656) |
3 entries |
ENSG00000167258 |
|
bile duct adenocarcinoma |
missense_variant |
0.5115% (2/391) |
1 entry |
ENSG00000167258 |
|
Malignant Ovarian Mixed Epithelial Tumor |
missense_variant |
20.0% (2/10) |
1 entry |
ENSG00000167258 |
|
hepatocellular carcinoma |
missense_variant |
1.218% (12/985) |
1 entry |
ENSG00000167258 |
|
colon adenocarcinoma |
conservative_inframe_deletion |
3.79% (49/1293) |
1 entry |
ENSG00000167258 |
|
brain glioblastoma |
missense_variant |
0.9076% (11/1212) |
1 entry |
ENSG00000167258 |
|
clear cell renal carcinoma |
sequence_alteration |
0.6766% (10/1478) |
1 entry |
ENSG00000167258 |
|
gastric adenocarcinoma |
stop_gained |
2.019% (19/941) |
1 entry |
ENSG00000167258 |
|
female breast carcinoma |
missense_variant |
1.496% (6/401) |
2 entries |
ENSG00000167258 |
|
colon adenocarcinoma |
sequence_alteration |
3.79% (49/1293) |
1 entry |
ENSG00000167258 |
|
ovarian serous adenocarcinoma |
missense_variant |
2.086% (19/911) |
2 entries |
ENSG00000167258 |
|
prostate carcinoma |
frameshift_variant |
3.512% (17/484) |
1 entry |
ENSG00000167258 |
|
non-small cell lung carcinoma |
missense_variant |
2.632% (3/114) |
3 entries |
ENSG00000167258 |
|
skin melanoma |
missense_variant |
2.238% (26/1162) |
4 entries |
ENSG00000167258 |
|
Invasive Breast Carcinoma |
missense_variant |
4.444% (2/45) |
1 entry |
ENSG00000167258 |
|
lung adenocarcinoma |
stop_gained |
1.362% (38/2789) |
3 entries |
ENSG00000167258 |
|
small cell lung carcinoma |
missense_variant |
1.57% (7/446) |
3 entries |
ENSG00000167258 |
|
melanoma |
frameshift_variant |
5.517% (8/145) |
2 entries |
ENSG00000167258 |
|
bladder transitional cell carcinoma |
missense_variant |
4.113% (19/462) |
3 entries |
ENSG00000167258 |
|
cecum adenocarcinoma |
frameshift_variant |
3.704% (10/270) |
2 entries |
ENSG00000167258 |
|
esophageal adenocarcinoma |
missense_variant |
3.467% (19/548) |
1 entry |
ENSG00000167258 |
|
bladder transitional cell carcinoma |
sequence_alteration |
4.113% (19/462) |
1 entry |
ENSG00000167258 |
|
squamous cell lung carcinoma |
stop_gained |
0.7984% (8/1002) |
1 entry |
ENSG00000167258 |
|
ovarian sarcoma |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000167258 |
|
diffuse gastric adenocarcinoma |
missense_variant |
1.22% (1/82) |
1 entry |
ENSG00000167258 |
|
Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
missense_variant |
3.03% (1/33) |
1 entry |
ENSG00000167258 |
|
Ampulla of Vater Carcinoma |
missense_variant |
1.176% (1/85) |
1 entry |
ENSG00000167258 |
|
melanoma |
sequence_alteration |
5.517% (8/145) |
1 entry |
ENSG00000167258 |
|
pharyngeal squamous cell carcinoma |
frameshift_variant |
1.399% (2/143) |
1 entry |
ENSG00000167258 |
|
ovarian carcinoma |
frameshift_variant |
9.091% (1/11) |
1 entry |
ENSG00000167258 |
|
small intestinal adenocarcinoma |
missense_variant |
9.524% (2/21) |
1 entry |
ENSG00000167258 |
|
skin melanoma |
frameshift_variant |
2.238% (26/1162) |
1 entry |
ENSG00000167258 |
|
basal cell carcinoma |
sequence_alteration |
10.29% (7/68) |
1 entry |
ENSG00000167258 |
|
leiomyosarcoma |
missense_variant |
0.9901% (1/101) |
1 entry |
ENSG00000167258 |
|
rectal adenocarcinoma |
stop_gained |
1.648% (9/546) |
1 entry |
ENSG00000167258 |
|
small cell lung carcinoma |
stop_gained |
1.57% (7/446) |
1 entry |
ENSG00000167258 |
|
urothelial carcinoma |
frameshift_variant |
8.14% (7/86) |
1 entry |
ENSG00000167258 |
|
cecum adenocarcinoma |
stop_gained |
3.704% (10/270) |
1 entry |
ENSG00000167258 |
|
meningioma (disease) |
missense_variant |
1.37% (1/73) |
1 entry |
ENSG00000167258 |
|
Thymic Carcinoma |
missense_variant |
9.091% (1/11) |
1 entry |
ENSG00000167258 |
|
undifferentiated pleomorphic sarcoma |
missense_variant |
1.613% (1/62) |
1 entry |
ENSG00000167258 |
|
neoplasm |
stop_gained |
3.448% (1/29) |
1 entry |
ENSG00000167258 |
|
testicular seminoma |
frameshift_variant |
2.353% (2/85) |
1 entry |
ENSG00000167258 |
|
gastric intestinal type adenocarcinoma |
frameshift_variant |
3.529% (3/85) |
1 entry |
ENSG00000167258 |
|
pancreatic ductal adenocarcinoma |
frameshift_variant |
1.863% (32/1718) |
1 entry |
ENSG00000167258 |
|
breast ductal adenocarcinoma |
conservative_inframe_deletion |
2.959% (49/1656) |
1 entry |
ENSG00000167258 |
|
female breast carcinoma |
stop_gained |
1.496% (6/401) |
1 entry |
ENSG00000167258 |
|
breast ductal adenocarcinoma |
frameshift_variant |
2.959% (49/1656) |
1 entry |
ENSG00000167258 |
|
Merkel cell skin cancer |
missense_variant |
2.128% (2/94) |
1 entry |
ENSG00000167258 |
|
pharyngeal squamous cell carcinoma |
missense_variant |
1.399% (2/143) |
1 entry |
ENSG00000167258 |
|
head and neck squamous cell carcinoma |
missense_variant |
0.159% (1/629) |
1 entry |
ENSG00000167258 |
|
gastric adenocarcinoma |
frameshift_variant |
2.019% (19/941) |
1 entry |
ENSG00000167258 |
|
Endometrial Clear Cell Adenocarcinoma |
missense_variant |
3.704% (1/27) |
1 entry |
ENSG00000167258 |
|
mucosal melanoma |
missense_variant |
1.429% (1/70) |
1 entry |
ENSG00000167258 |
|
ependymoma |
sequence_alteration |
1.852% (1/54) |
1 entry |
ENSG00000167258 |
|
papillary thyroid carcinoma |
missense_variant |
0.2028% (1/493) |
1 entry |
ENSG00000167258 |
|
brain glioblastoma |
frameshift_variant |
0.9076% (11/1212) |
1 entry |
ENSG00000167258 |
|
nasopharyngeal squamous cell carcinoma |
missense_variant |
0.3247% (1/308) |
1 entry |
ENSG00000167258 |
|
soft tissue sarcoma |
missense_variant |
0.3401% (1/294) |
1 entry |
ENSG00000167258 |
|
testicular seminoma |
sequence_alteration |
2.353% (2/85) |
1 entry |
ENSG00000167258 |
|
Gallbladder Adenocarcinoma |
sequence_alteration |
0.6061% (1/165) |
1 entry |
ENSG00000167258 |
|
oral squamous cell carcinoma |
missense_variant |
0.3817% (1/262) |
1 entry |
ENSG00000167258 |
|
Mediastinal Malignant Germ Cell Tumor |
stop_gained |
6.667% (1/15) |
1 entry |
ENSG00000167258 |
|
Lung Sarcomatoid Carcinoma |
missense_variant |
7.143% (1/14) |
1 entry |
ENSG00000167258 |
|
mucosal melanoma |
frameshift_variant |
1.429% (1/70) |
1 entry |
ENSG00000167258 |
|
adrenal cortex carcinoma |
missense_variant |
0.5291% (1/189) |
1 entry |
ENSG00000167258 |
|
hemangioblastoma |
sequence_alteration |
2.857% (1/35) |
1 entry |
ENSG00000167258 |
|
esophageal squamous cell carcinoma |
sequence_alteration |
1.895% (13/686) |
1 entry |
ENSG00000167258 |
|
large cell lung carcinoma |
missense_variant |
4.0% (1/25) |
1 entry |
ENSG00000167258 |
|
Pleural Epithelioid Mesothelioma |
missense_variant |
0.4878% (1/205) |
1 entry |
ENSG00000167258 |
|
small cell lung carcinoma |
frameshift_variant |
1.57% (7/446) |
1 entry |
ENSG00000167258 |
|
gastric adenocarcinoma |
conservative_inframe_deletion |
2.019% (19/941) |
1 entry |
ENSG00000167258 |
|
Merkel cell skin cancer |
stop_gained |
2.128% (2/94) |
1 entry |
ENSG00000167258 |
|
salivary gland carcinoma |
frameshift_variant |
3.03% (1/33) |
1 entry |
ENSG00000167258 |
|
lung adenocarcinoma |
frameshift_variant |
1.362% (38/2789) |
1 entry |
ENSG00000167258 |
|
cecum adenocarcinoma |
amino_acid_insertion |
3.704% (10/270) |
1 entry |
ENSG00000167258 |
|
endometrial carcinoma |
missense_variant |
3.448% (1/29) |
1 entry |
ENSG00000167258 |
|
lymphoid neoplasm |
missense_variant |
6.599% (13/197) |
1 entry |
ENSG00000167258 |
|
small intestinal adenocarcinoma |
frameshift_variant |
9.524% (2/21) |
1 entry |
ENSG00000167258 |
|
Adrenal Gland Neuroblastoma |
missense_variant |
1.667% (1/60) |
1 entry |
ENSG00000167258 |
|
neoplasm |
missense_variant |
3.448% (1/29) |
1 entry |
ENSG00000167258 |
|
clear cell renal carcinoma |
frameshift_variant |
0.6766% (10/1478) |
1 entry |
ENSG00000167258 |
|
pancreatic neuroendocrine tumor |
missense_variant |
3.814% (9/236) |
1 entry |
ENSG00000167258 |
|
small cell lung carcinoma |
sequence_alteration |
1.57% (7/446) |
1 entry |
ENSG00000167258 |
|
Pancreatic Acinar Cell Carcinoma |
missense_variant |
2.941% (1/34) |
1 entry |
ENSG00000167258 |
|
hepatocellular carcinoma |
frameshift_variant |
1.218% (12/985) |
1 entry |
ENSG00000167258 |
|
Uveal Melanoma |
missense_variant |
0.7812% (1/128) |
1 entry |